ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Deferoxamine → 3,4-Diacetoxy-1-butene

HRID 2393487
印刷

反応式

HRID 2393487 の反応式
N[C@H](C(N1C(=O)N[C@H]2[C@@H]1CS[C@H]2C[CH2:13][CH2:14][CH2:15][C:16](=[O:18])O)=O)CS.[CH3:23][C:24](N(O)CCCCCNC(CCC(N(O)CCCCCNC(CCC(N(O)CCCCCN)=O)=O)=O)=O)=[O:25].CS(O)(=O)=O.[OH-].[Na+].C1C(=O)N([O:76][C:77]([CH2:79]I)=[O:78])C(=O)C1.CC(N(O)CCCCCNC(CCC(N(O)CCCCCNC(CCC(N(O)CCCCCN)=O)=O)=O)=O)=O>CO>[CH3:23][C:24]([O:13][CH2:14][CH:15]([O:78][C:77]([CH3:79])=[O:76])[CH:16]=[CH2:18])=[O:25]
参加物実験手順後処理出典と根拠反応ノート

参加物

7

反応物 5

HCID 2973DeferoxamineHCID 14798Sodium Hydroxide2 回HCID 62881Deferoxamine MesylateHCID 3299230Iodoacetic acid N-hydroxysuccinimide esterHCID 131720825N-cysteinyl-biotin

生成物 1

HCID 27350013,4-Diacetoxy-1-butene

試薬・触媒・溶媒 1

HCID 887Methanol溶媒

実験手順

DACB was synthesized by covalently conjugating iodoacetyl-deferoxamine and N-cysteinyl-biotin by the following Scheme II. ##STR20## Solid deferoxamine mesylate was added to methanol for a concentration of 20 mM, followed by addition of NaOH to reach a final concentration of 20 mM NaOH. The solution was heated and maintained at 65°. Solid iodoacetic acid N-hydroxysuccinimide ester (NHS-IA) was added to the deferoxamine solution to a final molarity of 50mM NHS-IA and incubated for at least one hour at 65°. The resulting iodoacetyl-deferoxamine (IA-DFO) was purified by HPLC with an EM LiChroCART reverse phase column using a linear gradient of 0-10 ml 100% Buffer A (0.025M phosphate, pH 6, 2 mM NTA) and 10-60 ml 0-100% Buffer B (0.025M phosphate, pH 6, 2 mM NTA, 75% methanol). IA-DFO, but not unconjugated DFO, has an absorbance at 260 nm and thus was purified by measuring the absorbance of the eluate and collecting the fraction with absorbance at 260 nm.

後処理

  1. temperatureThe solution was heated
  2. temperaturemaintained at 65°
  3. waitincubated for at least one hour at 65°
  4. customThe resulting iodoacetyl-deferoxamine (IA-DFO) was purified by HPLC with an EM LiChroCART reverse phase column
  5. customthus was purified
  6. customcollecting the fraction with absorbance at 260 nm

出典と根拠

ORDレコード
ord-51bebd3a49be48da8d6c3ecbb677d478
出典データセット
uspto-grants-1998_09
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US05807879

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート